DOCSLIB.ORG

8/12/19 1 •Chlamydia •Gonorrhea •Trichomoniasis *Syphilis •Herpes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
8/12/19 1 •Chlamydia •Gonorrhea •Trichomoniasis *Syphilis •Herpes 8/12/19 Disclosures • Lupin: Advisory committee for Solosec • Merck: Nexplanon trainer • Pfizer pharmaceutical: Advisory Committee for Menopause Questionnaire/teaching tool • TherapeuticsMD: Advisory Committee for vaginal hormone insert Shelagh Larson DNP, APRN, WHNP, NCMP Distinguish the differential diagnosis of STI. Objectives • 1. The attendees will recognize the non-genital presentations of sexually transmitted infection in women and men. •Chlamydia •Herpes • 2. The attendees will understand the prescription therapy for STIs in alternative sites. •Gonorrhea •HPV • 3. The attendees will know the differential diagnosis of STI and other tradition infections. •Trichomoniasis •HIV *Syphilis STI Presentations Discharge Syndrome Genital Ulcer Syndromes Dermatologic Syndromes • Chlamydia • Herpes Simplex HPV Virus • Gonorrhea Secondary Syphilis • Primary Syphilis Disseminated Gonococcal • Trichomoniasis • Chancroid Infection • Bacterial vaginosis Pediculosis Pubis • Candidiasis 1 8/12/19 Facts • most frequently reported bacterial sexually transmitted infection in the US • The silent disease 75% of infected females and 50% males do not realize they have it • Transmitted: vaginally, anal, oral • Once an infected person has completed antibiotic treatment, they should be re-tested after approximately three months to make sure the condition is cured. • Almost 2/3 of new chlamydia infections occur among youth aged 15-24 years. most frequently reported bacterial STI in the United States • known as a ‘silent’ infection because most infected people are asymptomatic and It is estimated that 1 in 20 sexually active young women aged 14-24 years lack abnormal physical examination findings. has chlamydia Easily treated with Azithromycin Symptoms (if any) occur 1-3 weeks after exposure • Women • Men • –Abnormal Vaginal Discharge (Odor or Odorless) • Cloudy or Clear Discharge From the Tip of the Penis • –Spotting/Bleeding Between Periods • –Painful and Swollen Testicles • –Painful Periods • –Itching and/or Burning Around • –Pain During Sexual Intercourse the Opening of the Penis • –Painful Urination • –Painful Urination • –Abdominal Pain With Fever • –Burning and/or Itching in or Around the Vagina unilateral eye discomfort with hyperemia. The secretions may be mucopurulent, but are more typically clear to cloudy Chlamydial tonsillopharyngitis is marked by generalized pharyngeal and tonsillar hyperemia with possible addition of swollen anterior pillars and uvula, as well as diffuse purulent exudate on the tonsils Oztürk O, Seven H. Chlamydia trachomatis tonsillopharyngitis. Case Rep CDC/ Susan Lindsley Otolaryngol. 2012;2012:736107 2 8/12/19 Reactive arthritis (formerly Reiter’s syndrome) “Fitz-Hugh-Curtis Syndrome” • a post-inflammatory autoimmune disease that can result from urogenital chlamydia infection. • Characteristics of the syndrome include Some patients with chlamydial PID develop conjunctivitis, urethritis, oligoarthritis, and skin lesions (keratoderma perihepatitis, an inflammation of the liver blennorrhagica) and circinate balanitis • the onset is typically 3 to 6 weeks after capsule and surrounding peritoneum, which urogenital chlamydia infection and it can occur even in persons who receive effective treatment for chlamydia is associated with right upper quadrant pain. infection. • affects predominantly males, particularly those positive for HLA-B27, and it usually Source: photograph from Public Health—Seattle & King County STD Clinic. resolves within 3 to 6 months Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. Chlamydial infections. MMWR Recomm Rep. 2015;64(No. RR-3):1-137 Treatment : CZ, and you would be mad! Screening recommendations: Azithromycin 1 g po a single dose Women Men (Doxycycline 100 mg po BID x 7 days) • Sexually active women under 25 years of age, • *Consider screening young men in high prevalence clinical settings or in • Sexually active women aged 25 years and older if at • an oropharyngeal infection should be treated increased risk populations with high burden of infection (e.g. MSM) with azithromycin or doxycycline. • Test for reinfection approximately 3 months after treatment Men Who have Sex With Men (MSM) For rectal chlamydial infections, some experts prefer Pregnant Women • At least annually for sexually active MSM using doxycycline rather than azithromycin • Retest during the 3rd trimester for women under 25 at sites of contact (urethra, rectum) years of age or at risk regardless of condom use Pregnancy with Azithromycin allergy: • Should have a TOC 3-4 weeks after treatment and be • Every 3 to 6 months if at increased risk Amoxicillin 500 mg po TID x 7 days retested during the third trimester. Persons with HIV • Routine oropharyngeal screening for CT is not Alternative Regimens recommended, although evidence suggests it can be • sexually transmitted to genital sites For sexually active individuals, screen at first HIV evaluation, and at least annually Erythromycin base 500 mg po QID x 7 days • diagnostic accuracy indicate that screening for thereafter Erythromycin ethyl succinate 800 mg po QID x 7 days chlamydia and gonorrhea with NAATs is highly accurate for specimens from various anatomical sites Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted Levofloxacin 500 mg po qD x7 days for women and men CDC, 2017. Chlamydia Fact sheet. detailed diseases treatment guidelines, 2015. Chlamydial infections. MMWR Recomm Rep. 2015;64(No. https://www.cdc.gov/std/chlamydia/stdfact-chlamydia-detailed.htm RR-3):1-137 Ofloxacin 300 mg PO BID x7 days Gonorrhea • caused by the bacteria Neisseria gonorrhoeae • When symptoms are present they can include thick white or yellow/greenish discharge, painful urination, increased urination, sore throat and severe pain in lower abdomen. 3 8/12/19 Who gets it? Symptoms • Any sexually active person can be infected with gonorrhea. • Unpleasant smelling and • Discomfort while having • In the United States, the highest reported rates of infection are among frothy vaginal discharge intercourse sexually active teenagers, young adults, and African Americans • Itching in and around the • Green, white, yellow or gray • transmitted through sexual contact with the penis, vagina, mouth, or vaginal area vaginal discharge anus of an infected partner. • • • Ejaculation does not have to occur for gonorrhea to be transmitted or Blood spotting in discharge Genital swelling or redness acquired. • Frequent urination • Low abdominal pain in rare • Gonorrhea can also be spread perinatally from mother to baby during accompanied by burning cases childbirth. sensation and pain • Groin swelling Screening recommendations: Gonorrhea Women Men Who have Sex With Men (MSM) • Sexually active women under 25 • At least annually for sexually active MSM at sites of years of age contact (urethra, rectum, pharynx) regardless of condom use • Sexually active women age 25 years • Every 3 to 6 months if at increased risk Pharyngeal infection may cause a and older if at increased risk • testing of urine specimens was slightly more sore throat, but usually is sensitive than urethral specimens Courtesy of the CDC asymptomatic • Retest 3 months after treatment Consider one-time lavage of the Pregnant Women infected eye with saline solution Persons with HIV • All under 25 years of age and older • For sexually active individuals, screen at first HIV Culture is available for detection of rectal, women if at increased risk evaluation, and at least annually thereafter oropharyngeal, and conjunctival gonococcal • More frequent screening for might be appropriate infection, but NAAT is not FDA-cleared for • Retest 3 months after treatment depending on individual risk behaviors and the local use with these specimens. Yet some have epidemiology met CLIA regulatory requirements and • Retest in 3rd Trimester if continual risk Courtesy of the CDC/Joe Miller Courtesy of the CDC established performance specifications for Culture is available for detection of rectal, oropharyngeal, and conjunctival gonococcal infection, WorkowskiKA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. using NAAT with rectal and oropharyngeal Gonococcal infections. MMWR Recomm Rep. 2015;64(No. RR-3):1-137. but NAAT is not FDA-cleared for use with these specimens. swab specimens . https://www.std.uw.edu/custom/self-study/gonorrhea Gonorrhea: • Ceftriaxone 250 mg IM/single dose “Happy Hour” PLUS If ceftriaxone is not available or • Azithromycin 1g po/single dose Expedited Partner Therapy: on the same day, same time • safe and effective for tx of uncomplicated gonorrhea at all anatomic sites, curing 99.2% of •Cefixime 400 mg orally in a single dose urogenital and anorectal infections and 98.9% of pharyngeal infections in clinical trial. PLUS Conjunctivitis: Ceftriaxone 1 g IM/single dose +Azithromycin 1 g po/single dose • Azithromycin 1 g orally in a single dose • Laws and regulations in all states require clinicians, laboratories, or both to report persons Laws and regulations in all states require clinicians, laboratories, or both to report persons with gonorrhea to public with gonorrhea to public health authorities. health authorities. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. Gonococcal infections. MMWR Recomm Rep. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted
Load more

Recommended publications
  • Histopathology and Laboratory Features of Sexually Transmitted Diseases
    Histopath & Labs for STIs Endo, Energy and Repro 2017-2018 HISTOPATHOLOGY AND LABORATORY FEATURES OF SEXUALLY TRANSMITTED DISEASES Dominck Cavuoti, D.O. Phone: 469-419-3412 Email: [email protected] LEARNING OBJECTIVES: • Identify the etiologic agents causing pelvic inflammatory disease and the pathologic changes they produce. • Discuss the characteristic clinical and pathologic findings caused by herpes simplex virus (HSV) infections: a. fever blisters b. genital herpes simplex virus infection c. disseminated neonatal HSV • Describe the pathologic changes produced by Treponema pallidum. • Describe the clinical features and pathologic changes produced by Chlamydia trachomatisand Neisseria gonorrhoeae • Describe the clinical and laboratory features of vaginal infections including: Trichomonas, Candida, and bacterial vaginosis. • Describe the clinical and laboratory features of ectoparasite infections PURPOSE OF THE LECTURE: 1. To describe the various agents of sexually transmitted diseases and their disease manifestations 2. To describe the pathologic features associated with STDs 3. To introduce some of the laboratory aspects of STDs TERMS INTRODUCED IN LECTURE: Condyloma lata Disseminated gonococcal infection Gummatous syphilis Lymphogranuloma venereum Pelvic inflammatory disease Rapid Plasma Reagin (RPR) Salpingitis Syphilis/endarteritis obliterans Venereal Disease Research Laboratory (VDRL) Treponema pallidum particle agglutination (TPPA) Histopath & Labs for STIs Endo, Energy and Repro 2017-2018 MAJOR CONCEPTS EMPHASIZED IN LECTURE I. Syphilis (Will be covered by Dr. Norgard in later lecture). II. Gonorrhea A. Causative agent: Neisseria gonorrhoeae, a Gram negative diplococcus. Humans are the only natural reservoir. Infection is acquired via direct contact with the mucosa of an infected person. The incubation period averages 2-5 days with a range of 1-14 days.
    [Show full text]
  • Trichomoniasis — “Trich” for Short — Is an Infection That Is Most Common in Sexually Active Women Age 16 to 35
    FACT SHEET FOR PATIENTS AND FAMILIES Trichomoniasis What is trichomoniasis? Trichomoniasis — “trich” for short — is an infection that is most common in sexually active women age 16 to 35. (Men can have trich, too, but usually have fewer symptoms and often don’t need treatment to clear up the infection.) If you have trich, you need medication to stop your symptoms and prevent spreading the infection to sex partners. This handout gives you basic information on trichomoniasis, how it’s treated, and what you can do to prevent it. What causes it? Trichomoniasis is caused by a parasite, a tiny organism called Trichomonas vaginalis. Trich is passed from one person to another through sexual contact. Trich is one of the most common sexually transmitted infections or diseases (STIs or STDs) among young, sexually active women. Recent studies suggest that more Most common in young women, than 2 million women in the U.S. currently have trichomoniasis is a curable infection. trichomoniasis. Why is it a concern? What are the symptoms? Trich is completely curable, but you shouldn’t ignore A woman with trichomoniasis may have one or it. Trich can cause annoying and painful symptoms more of these common symptoms, which may (see the list at right) and may make it easier to catch come and go: another STI such as HIV, the virus that causes AIDS. • Vaginal discharge. The discharge may be gray, If you’re pregnant, trich brings these additional risks: yellow, or green. It may be thin or foamy and may • Your baby may be born too soon smell bad.
    [Show full text]
  • Trichomoniasis Information Handout for Patients
    Ottawa County Department of Public Health Family Planning Program Trichomoniasis Information Handout for Patients Trichomoniasis is a sexually transmitted infection caused by the parasite Trichomonas vaginalis. Causes: Trichomoniasis is found worldwide. In the United States, the highest number of cases are seen in women between age 16 and 35. Trichomonas vaginalis is spread through sexual contact with an infected partner. This includes penis-to-vagina intercourse or vulva-to-vulva contact. The parasite cannot survive in the mouth or rectum. The disease can affect both men and women, but the symptoms differ between the two groups. The infection usually does not cause symptoms in men and goes away on its own in a few weeks. Symptoms in Women: •Discomfort with intercourse •Itching of the inner thighs •Vaginal discharge (thin, greenish-yellow, frothy or foamy) •Vaginal itching •Vulvar itching or swelling of the labia •Vaginal odor (foul or strong smell) Symptoms in Men: •Burning after urination or ejaculation •Itching of urethra •Slight discharge from urethra Occasionally, some men with trichomoniasis may develop prostatitis or epididymitis from the infection. Exams and Tests: In women, a pelvic examination shows red blotches on the vaginal wall or cervix. A wet prep (microscopic examination of discharge) may show signs of inflammation or infection-causing organisms in vaginal fluids. A pap smear may also diagnose the condition. The disease can be hard to diagnose in men. Men are treated if the infection is diagnosed in any of their sexual partners. Men may also be treated if they have ongoing symptoms of urethral burning or itching despite treatment for gonorrhea and chlamydia.
    [Show full text]
  • Trichomoniasis Trichomoniasis Is the Most Common Curable Sexually Transmitted Disease (STD) in the United States
    Neglected Parasitic Infections in the United States Trichomoniasis Trichomoniasis is the most common curable sexually transmitted disease (STD) in the United States. Trichomoniasis is caused by infection with a parasite (Trichomonas vagi- nalis). Women and men who have trichomoniasis are at higher risk for getting or spreading other STDs, including HIV. About 3.7 million people in the United States are infected with this parasite, and most do not have any signs or symptoms. Trichomoniasis is treated with prescription antimicrobial medication (one dose of metronidazole or tinidazole) but it is possible to become infected again. Trichomoniasis is considered a Neglected Parasitic Infection, one of a group of diseases that can result in serious illness among those who are infected, yet the burden and impact remain poorly understood. How People get Trichomoniasis: Trichomoniasis is a sexually transmitted disease (STD); the parasite is passed from an infected person to an uninfected person during sex. Women and men with trichomoniasis may notice redness, soreness, or itching of the genitals, burning with urination, or discharge. Without treatment, infection can last for months or even years. Some people develop symptoms within 5 to 28 days after being infected, but others do not develop symp- toms until much later or not at all. About 70% of infected people never have any signs or symptoms. Even without any Trichomonas symptoms, infected people can pass the infection to others. Risk Factors for Acquiring Trichomoniasis: • Both men and women can get infected. • People with more sexual partners are more likely to become infected. • Older women may be more likely than younger women to be infected.
    [Show full text]
  • Sexually Transmitted Infections
    Disease Awareness April, 2014 • Members Sexually Transmitted Infections Many infections are spread during sex. In this newsletter, we will talk about the 4 most common ones. Human papillomavirus (HPV) Protect yourself What it causes • Learn about sexually transmitted infections Most of the time HPV goes away on its own and doesn’t cause any problems. But many low-risk types of HPV can cause genital warts. High-risk types can • Practice safe sex cause cervical cancer. • Get tested Symptoms Genital warts are a sign of infection with a low-risk type of HPV. The warts can • Get vaccinated to protect against sometimes itch, burn, or feel tender. They can cause bleeding after sex or an HPV and hepatitis B abnormal fluid coming from the vagina. Not all people will have symptoms. There are no symptoms of the high-risk type of HPV. But signs of an infection can be seen on a Pap smear. Testing Testing is not needed to diagnose the low-risk type. But doctors might test these people for infection with a high-risk type. This is because people with genital warts are sometimes infected with both low-risk and high-risk types of HPV. Since there are no symptoms of the high-risk type, it’s very important for women to be screened. Doctors use the Pap test for this and an HPV DNA test that can detect high-risk types. Talk with your doctor about testing if you are 21 years old or older. Treatment HPV that causes genital warts cannot be cured. Medication can be used to help the warts go away.
    [Show full text]
  • Sexually Transmitted Diseases Treatment Options
    Sexually transmitted disease (STD) treatment options PREFERRED & ALTERNATIVE OPTIONS Many clinical partners are operating in a limited capacity during the COVID-19 pandemic. Below are preferred (in clinic or other location where injections can be given) and alternative (when only oral medicines are available 1) treatments for STDs. Syndrome Preferred Treatments Alternative Treatments Follow-up Male urethritis syndrome Ceftriaxone 250mg intramuscular (IM) x 1 PLUS Men who have sex with men (MSM) and transgender women2: Patients should be counseled to azithromycin 1g PO x 1 Cefixime 800 mg PO x 1 PLUS doxycycline 100 mg PO BID x 7 days be tested for STDs once clinical Presumptively treating: care is resumed in the local If azithromycin is not available: doxycycline 100 Men who have sex with women only: gonorrhea clinics. Clients who have been mg PO BID for 7 days (except in pregnancy3) Cefixime 800mg PO x 1 PLUS azithromycin 1g PO x 1 referred for oral treatment If cephalosporin allergy5 is reported, gentamicin If cefixime is unavailable, substitute cefpodoxime 400mg PO q12h should return for 240mg IM x 1 PLUS azithromycin 2g PO x 1 x 2 for cefixime in above regimens4 comprehensive testing and screening and linked to services If oral cephalosporin not available or history of cephalosporin at that time. allergy5: azithromycin 2g PO x 1 If azithromycin is not available: doxycycline 100 mg PO BID for 7 days (except in pregnancy3) Patients should be advised to abstain from sex for 7 days Treatment typically guided by examination and For presumptive therapy when examination and laboratory following completion of Vaginal discharge syndrome treatment.
    [Show full text]
  • Genital Dermatology
    GENITAL DERMATOLOGY BARRY D. GOLDMAN, M.D. 150 Broadway, Suite 1110 NEW YORK, NY 10038 E-MAIL [email protected] INTRODUCTION Genital dermatology encompasses a wide variety of lesions and skin rashes that affect the genital area. Some are found only on the genitals while other usually occur elsewhere and may take on an atypical appearance on the genitals. The genitals are covered by thin skin that is usually moist, hence the dry scaliness associated with skin rashes on other parts of the body may not be present. In addition, genital skin may be more sensitive to cleansers and medications than elsewhere, emphasizing the necessity of taking a good history. The physical examination often requires a thorough skin evaluation to determine the presence or lack of similar lesions on the body which may aid diagnosis. Discussion of genital dermatology can be divided according to morphology or location. This article divides disease entities according to etiology. The clinician must determine whether a genital eruption is related to a sexually transmitted disease, a dermatoses limited to the genitals, or part of a widespread eruption. SEXUALLY TRANSMITTED INFECTIONS AFFECTING THE GENITAL SKIN Genital warts (condyloma) have become widespread. The human papillomavirus (HPV) which causes genital warts can be found on the genitals in at least 10-15% of the population. One study of college students found a prevalence of 44% using polymerase chain reactions on cervical lavages at some point during their enrollment. Most of these infection spontaneously resolved. Only a minority of patients with HPV develop genital warts. Most genital warts are associated with low risk HPV types 6 and 11 which rarely cause cervical cancer.
    [Show full text]
  • Trichomoniasis (Trich)
    health information Trichomoniasis (Trich) Trich is a sexually transmitted infection (STI) caused by a parasite called Trichomonas vaginalis. How do I get trich? Trich is passed between people through unprotected sex (sexual contact without a condom). How can I prevent trich? When you’re sexually active, the best way to prevent trich and other STIs is to use condoms for oral, vaginal, and anal sex. Don’t have any sexual contact if you or your partner(s) have symptoms of an STI, or may have been exposed to an STI. See a doctor or go to an STI Clinic for testing. Get STI testing every 3 to 6 months and when you have symptoms. How do I know if I have trich? The infection is most common in females in the vagina and in males in the tube that carries urine and semen (urethra). Many women with trich have no symptoms, but trich can cause: • vaginal discharge that smells musty • itching in and around the vagina • pain or burning when you pee • pain during intercourse Most males with trich have no symptoms, but they can still spread it. The best way to find out if you have trich is to get tested. Your nurse or doctor can test you by taking a swab. Is trich harmful? If not treated, trich may cause: • infertility or low sperm count in males • increased risk of pelvic infections in females • increased risk of getting other STIs and HIV 608183 © Alberta Health Services, (2014/04) What if I’m pregnant? If not treated, trich may cause premature rupture of the membranes, early delivery, and low birth weight.
    [Show full text]
  • Chlamydia, Gonorrhoea, Trichomoniasis and Syphilis
    Research Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016 Jane Rowley,a Stephen Vander Hoorn,b Eline Korenromp,c Nicola Low,d Magnus Unemo,e Laith J Abu- Raddad,f R Matthew Chico,g Alex Smolak,f Lori Newman,h Sami Gottlieb,a Soe Soe Thwin,a Nathalie Brouteta & Melanie M Taylora Objective To generate estimates of the global prevalence and incidence of urogenital infection with chlamydia, gonorrhoea, trichomoniasis and syphilis in women and men, aged 15–49 years, in 2016. Methods For chlamydia, gonorrhoea and trichomoniasis, we systematically searched for studies conducted between 2009 and 2016 reporting prevalence. We also consulted regional experts. To generate estimates, we used Bayesian meta-analysis. For syphilis, we aggregated the national estimates generated by using Spectrum-STI. Findings For chlamydia, gonorrhoea and/or trichomoniasis, 130 studies were eligible. For syphilis, the Spectrum-STI database contained 978 data points for the same period. The 2016 global prevalence estimates in women were: chlamydia 3.8% (95% uncertainty interval, UI: 3.3–4.5); gonorrhoea 0.9% (95% UI: 0.7–1.1); trichomoniasis 5.3% (95% UI:4.0–7.2); and syphilis 0.5% (95% UI: 0.4–0.6). In men prevalence estimates were: chlamydia 2.7% (95% UI: 1.9–3.7); gonorrhoea 0.7% (95% UI: 0.5–1.1); trichomoniasis 0.6% (95% UI: 0.4–0.9); and syphilis 0.5% (95% UI: 0.4–0.6). Total estimated incident cases were 376.4 million: 127.2 million (95% UI: 95.1–165.9 million) chlamydia cases; 86.9 million (95% UI: 58.6–123.4 million) gonorrhoea cases; 156.0 million (95% UI: 103.4–231.2 million) trichomoniasis cases; and 6.3 million (95% UI: 5.5–7.1 million) syphilis cases.
    [Show full text]
  • Sexually Transmitted Diseases Treatment Guidelines, 2015
    Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015 Sexually Transmitted Diseases Treatment Guidelines, 2015 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS CONTENTS (Continued) Introduction ............................................................................................................1 Gonococcal Infections ...................................................................................... 60 Methods ....................................................................................................................1 Diseases Characterized by Vaginal Discharge .......................................... 69 Clinical Prevention Guidance ............................................................................2 Bacterial Vaginosis .......................................................................................... 69 Special Populations ..............................................................................................9 Trichomoniasis ................................................................................................. 72 Emerging Issues .................................................................................................. 17 Vulvovaginal Candidiasis ............................................................................. 75 Hepatitis C ......................................................................................................... 17 Pelvic Inflammatory
    [Show full text]
  • Sexually Transmitted Infections–Summary of CDC Treatment
    Sexually Transmitted Infections Summary of CDC Treatment Guidelines—2021 Bacterial Vaginosis • Cervicitis • Chlamydial Infections • Epididymitis Genital Herpes Simplex • Genital Warts (Human Papillomavirus) • Gonococcal Infections Lymphogranuloma Venereum • Nongonococcal Urethritis (NGU) • Pediculosis Pubis Pelvic Inflammatory Disease• Scabies • Syphilis • Trichomoniasis U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention National Network of STD Clinical Prevention Training Centers This pocket guide reflects recommended regimens found in CDC’s Sexually Transmitted Infections Treatment Guidelines, 2021. This summary is intended as a source of clinical guidance. When more than one therapeutic regimen is recommended, the sequence is in alphabetical order unless the choices for therapy are prioritized based on efficacy, cost, or convenience. The recommended regimens should be used primarily; alternative regimens can be considered in instances of substantial drug allergy or other contraindications. An important component of STI treatment is partner management. Providers can arrange for the evaluation and treatment of sex partners either directly or with assistance from state and local health departments. Complete guidelines can be viewed online at https://www.cdc.gov/std/treatment/. This booklet has been reviewed by CDC in July 2021. Accessible version: https://www.cdc.gov/std/treatment-guidelines/default.htm Bacterial Vaginosis Risk Category
    [Show full text]
  • New Medications for BV, Trich, Candida/Yeast, and Herpes
    New Medications for BV, Trich, Candida/Yeast, and Herpes New Medications are now available from ITEAMS to treat Bacterial Vaginosis (BV), Trichomoniasis (Trich), Candida/Yeast, Scabies, and Herpes. You can order these medications if you have the ability to test for these infections. Locations who offer only “express visits” (i.e., a blood specimen is collected for HIV and Syphilis and a urine specimen is collected for Gonorrhea and Chlamydia) will not be able to order the new medications. 340B requires providers to have an established relationship with the patient in order to provide medications purchased with 318 funds. A new form must be completed to have these medications added to the list of STD medications you can order through ITEAMS. These medications will be ordered through a new “program” under STD in ITEAMS called “STDT2”. Valacyclovir will be available as: #20 (for Initial HSV Outbreak): 1g po BID x 10 days #5 (for Recurrent HSV Outbreaks: 1g po qd x 5 days Metronidazole will be available as: #4 (for Trichomoniasis): 2 g orally in a single dose #14 (for Bacterial Vaginosis): 500mg BID x 7 days Fluconazole (Brand name Diflucan) #1 (for vulvovaginal yeast infection): 150 mg orally in a single dose 340B requires providers to have an established relationship with the patient in order to provide medications purchased with 318 funds. If you have patients who cannot afford their prescription for the above medications and you are an “express only” clinic, there is an option that is available but it requires some additional steps: 1-Obtain the patient’s consent on agency Release of Information, 2-Request the medical record of the patient as it relates to his/her diagnosis of Herpes, Bacterial Vaginosis, Trichomoniasis, or Candida/Yeast and the medication prescribed.
    [Show full text]